@jayvonsu@lowcortisol@PookiesParadise I certainly hope so, there’s 250 million white ppl in the US and 46 million blacks, now look up per capita I’ll wait.
@unusual_whales If only we can find a superconductor that can operate at room temperature this would become mainstream. I don’t think people have chambers with -273 Celsius in their home
@S_P_E_N_C_E_R_2 @unusual_whales It’s not bad I have it, ppl gotta get off their phones. If you have like 11-12 hours of a screen time a day this isn’t the phone for you
@eddcollinsx Tbh I think the market is reacting to Trumps order allowing nuclear energy companies to recycle plutonium from coldwar era nukes. It’s only 20 tons of material that doesn’t move the needle long term but definitely a good time to wait and see, potentially DCA.
@chamath OpenAI’s valuation just blows my mind, half a trillion with an annual burn of $9b that’s just exponentially increasing. Definitely uncharted territory here, we have no reference point in history to compare this to
@Mayhem4Markets It’s Sam Altman funded and now there’s a new trump appointed NRC chair who is following is SMR push. If anything this is a good sign they don’t have a ton of employees and burning costs they’re submitting their application to the NRC in Q4 2025 which absolutely will be approved
@unusual_whales Why does this race matter? Solar takes up so much land, it’s expensive, and the energy density isn’t there? The country who achieves and implements Nuclear Fusion is all that matters. It’s legitimately the power of the sun, in the mean time SMRs will do
@financecarguy_ @unusual_whales Honestly I don’t do silver just gold, so I’m definitely not the right person to ask. For me personally, gold is really the only hedge that I’d consider
@ditinlongisland @unusual_whales Agreed but think of it like this, I read that estimated 15-20mm ppl in the US are on GLP-1s, at a sticker price of $12k a year. That’s $180b - $240b a year, that’s absolutely insane I think around 40%~ of prescription spending. We need regulation from dbag big pharma